CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy
12 apr 2016 ·
2 min. 29 sec.
![CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/3a33ce4c3138e5f11344948e53f503df.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.
Informazioni
Autore | cancerGRACE |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company